These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12362216)

  • 21. Evaluation of treatment for gastro-oesophageal reflux disease with a proton pump inhibitor, and relationship between gastro-oesophageal reflux disease and Helicobacter pylori infection in Japan.
    Muramatsu A; Azuma T; Okajima T; Ohtani M; Dojo M; Yamazaki Y; Kuriyama M
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():102-6. PubMed ID: 15298614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative assessment of gastric corpus atrophy in subjects using omeprazole: a randomized follow-up study.
    van Grieken NC; Meijer GA; Weiss MM; Bloemena E; Lindeman J; Baak JP; Meuwissen SG; Kuipers EJ
    Am J Gastroenterol; 2001 Oct; 96(10):2882-6. PubMed ID: 11693321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastroesophageal reflux disease after Helicobacter pylori eradication in gastric ulcer patients: a one-year follow-up study.
    Jonaitis L; Kiudelis G; Kupcinskas L
    Medicina (Kaunas); 2008; 44(3):211-5. PubMed ID: 18413988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus.
    Csendes A; Smok G; Cerda G; Burdiles P; Mazza D; Csendes P
    Dis Esophagus; 1997 Jan; 10(1):38-42. PubMed ID: 9079272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: a study from the East.
    Wu JC; Sung JJ; Ng EK; Go MY; Chan WB; Chan FK; Leung WK; Choi CL; Chung SC
    Am J Gastroenterol; 1999 Jul; 94(7):1790-4. PubMed ID: 10406236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
    Adachi K; Hashimoto T; Komazawa Y; Mihara T; Furuta K; Fujishiro H; Ishihara S; Amano Y; Hattori S; Kinoshita Y
    Dig Liver Dis; 2005 Jul; 37(7):485-90. PubMed ID: 15975534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
    Kayser S; Flury R; Zbinden R; Fried M; Wirth HP
    Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical characteristics of gastroesophageal reflux diseases and association with Helicobacter pylori infection].
    Kim BC; Yoon YH; Jyung HS; Chung JB; Chon CY; Lee SI; Lee YC
    Korean J Gastroenterol; 2006 May; 47(5):363-9. PubMed ID: 16714878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review article: Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management.
    O'Connor HJ
    Aliment Pharmacol Ther; 1999 Feb; 13(2):117-27. PubMed ID: 10102940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus.
    Vaezi MF; Falk GW; Peek RM; Vicari JJ; Goldblum JR; Perez-Perez GI; Rice TW; Blaser MJ; Richter JE
    Am J Gastroenterol; 2000 Sep; 95(9):2206-11. PubMed ID: 11007219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypergastrinaemia during long-term omeprazole therapy: influences of vagal nerve function, gastric emptying and Helicobacter pylori infection.
    Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Bloemena E; Nelis GF; Festen HP; Jansen EH; Biemond I; Lamers CB; Meuwissen SG
    Aliment Pharmacol Ther; 1998 Jul; 12(7):605-12. PubMed ID: 9701523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
    Langtry HD; Wilde MI
    Drugs; 1998 Sep; 56(3):447-86. PubMed ID: 9777317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does Helicobacter pylori infection protect against esophageal diseases in Asia?
    Wu JC
    Indian J Gastroenterol; 2011 Jul; 30(4):149-53. PubMed ID: 21870139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lansoprazole and omeprazole in the treatment of acid peptic disorders.
    Blum RA
    Am J Health Syst Pharm; 1996 Jun; 53(12):1401-15. PubMed ID: 8781686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does Helicobacter pylori infection contribute to gastroesophageal reflux disease?
    Spechler SJ
    Yale J Biol Med; 1998; 71(2):143-8. PubMed ID: 10378360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rabeprazole: an update of its use in acid-related disorders.
    Carswell CI; Goa KL
    Drugs; 2001; 61(15):2327-56. PubMed ID: 11772142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies.
    Laine L; Sugg J
    Am J Gastroenterol; 2002 Dec; 97(12):2992-7. PubMed ID: 12492181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recent view of gastro-esophageal reflux disease according to the guideline for gastric ulcer treatment].
    Shirakawa K; Nakamura T; Masuyama H; Hiraishi H; Terano A
    Nihon Rinsho; 2004 Aug; 62(8):1559-64. PubMed ID: 15344551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of cure of Helicobacter pylori infection on gastric acidity and gastroesophageal reflux: study by 24-h pH monitoring in patients with gastric or duodenal ulcer.
    Fukuchi T; Ashida K; Yamashita H; Kiyota N; Tsukamoto R; Takahashi H; Ito D; Nagamatsu R
    J Gastroenterol; 2005 Apr; 40(4):350-60. PubMed ID: 15870971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa.
    Goldblum JR; Richter JE; Vaezi M; Falk GW; Rice TW; Peek RM
    Am J Gastroenterol; 2002 Feb; 97(2):302-11. PubMed ID: 11866266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.